Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Erlinda Quijano"'
Publikováno v:
Cancer Gene Therapy. 12:691-698
Cultured primary human cells have been widely used to assess the selectivity of oncolytic viruses as potential anticancer agents. As culture conditions can potentially have a significant impact on virus replication and ultimately cell killing, we eva
Autor:
Van Tsai, Heidrun Engler, Murali Ramachandra, Todd Machemer, Erlinda Quijano, Robert O. Ralston, Jennifer Philopena, Shu-Fen Wen
Publikováno v:
Virology. 328(1):52-61
Replication competent adenoviruses with various E1 modifications designed to restrict their replication to tumor cells are being evaluated as oncolytic agents in clinical trials. In mouse models, we observed that such oncolytic adenoviruses showed gr
Autor:
David W. Kang, Monica L. Zepeda, Barry J. Sugarman, Erlinda Quijano, Danling Gu, L. David Looper
Publikováno v:
Molecular Therapy. 13
Excessive scarring is a significant clinical problem, resulting in both adverse tissue form and function. We have previously demonstrated that a recombinant adenovirus encoding the cyclin-dependent kinase inhibitor p21 (rAd-p21), attenuated cell prol
Autor:
Suzie H. Pun, Nathalie C. Bellocq, Thomas Schluep, Greg Jensen, Todd Machemer, Erlinda Quijano, Jeremy D. Heidel, Shu-Fen Wen, Heidrun Engler, Mark E. Davis, Aijie Liu
Publikováno v:
Bioconjugate chemistry. 15(4)
Linear and branched poly(ethylenimines), lPEI and bPEI, respectively, grafted with beta-cyclodextrin are prepared to give CD-lPEI and CD-bPEI, respectively, and are investigated as in vitro and in vivo nonviral gene delivery agents. The in vitro toxi
Autor:
G William, Demers, Duane E, Johnson, Van, Tsai, Shu-Fen, Wen, Erlinda, Quijano, Todd, Machemer, Jennifer, Philopena, Murali, Ramachandra, John A, Howe, Paul, Shabram, Robert, Ralston, Heidrun, Engler
Publikováno v:
Cancer research. 63(14)
Central to the development of oncolytic virotherapies for cancer will be a better understanding of the parameters that influence the outcome of virotherapy to treat disseminated cancer by i.v. administration versus regional disease by local treatment
Autor:
Thomas Schluep, Maneval Daniel, Alexis E Harper, Shu-Fen Wen, Todd Machemer, Susan E. Conroy, Erlinda Quijano, Heidrun Engler, Ken N. Wills
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 7(4)
We conducted a series of experiments to determine if intraperitoneal (IP) delivery of recombinant adenovirus (rAd)-based therapies is improved through carrier vehicle selection, and compared an icodextrin solution (a high molecular weight dextrin wit
Autor:
Erlinda Quijano, Jeremy Shinoda, Shu Fen Wen, Yuetian Chen, Grace Michael, Ingo Runnenbaum, JoAnn Horowitz, Beth Hutchins, Mary Lynn Musco-Hobkinson, Dan Maneval, Tong-Yuan Yang, Vikas Mahavni, Richard E. Buller
Publikováno v:
Cancer gene therapy. 10(3)
A cohort study was designed to evaluate the efficiency of gene transfer and whether biological activity from the expressed therapeutic gene resulted after administration of a recombinant adenovirus containing the human wild-type p53 (p53(wt)) gene (r
Autor:
Daniel C. Maneval, Christoph Huber, Jürgen Kuball, Derek Atkins, Grace Michael, Erlinda Quijano, Joachim W. Thüroff, Heidrun Engler, Mary Ann Fritz, Shu Fen Wen, Joachim Leissner, Beth Hutchins, S. Störkel, Patricia Meinhardt, Martin Schuler
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20(4)
PURPOSE: To study safety, feasibility, and biologic activity of adenovirus-mediated p53 gene transfer in patients with bladder cancer. PATIENTS AND METHODS: Twelve patients with histologically confirmed bladder cancer scheduled for cystectomy were tr
Autor:
Erlinda Quijano, Danling Gu, David W. Kang, Monica L. Zepeda, David Looper, Shu Fen Wen, Diane McAllister
Publikováno v:
Molecular Therapy. 11:S290-S291
Understanding where genes are being expressed in normal, wounded and wound impaired skin, along with the duration of expression after transduction by recombinant adenovirus (rAd) is an important factor relevant to gene therapy strategies. Recombinant